CTT Pharmaceutical (CTTH) CEO Buys 9,800 Shares

What Happened

• The CEO of CTT Pharmaceutical Holdings, Inc. acquired 9,800 shares in an open-market purchase (transaction code P) on 2026-09-04 at $0.05 per share, for a total cost of approximately $479. This is a purchase (a bullish action in form), though the dollar amount is very small.

Key Details

• Transaction date: 2026-09-04; Filing date: 2026-09-04
• Price per share: $0.05; Shares acquired: 9,800; Total value: ~$479
• Transaction type: P = Purchase (open market/private purchase)
• Shares owned after transaction: not specified in the provided filing excerpt
• Footnotes/plan: no 10b5-1 plan, tax withholding, or other special footnotes noted in the data provided
• Timeliness: filed same day as reported transaction date in the provided data; no late filing indicated

Context

• Insider purchases can be more informative than sales, but this purchase is very small in dollar terms ($479) and may be routine or for minor allocation reasons rather than a strong signal of conviction. No additional details (e.g., a trading plan or resulting ownership percentage) were included in the excerpt.